Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04697797 |
|
Recruitment Status :
Recruiting
First Posted : January 6, 2021
Last Update Posted : January 27, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Bradyarrhythmia | Other: Device Programming |
Permanent His Bundle Pacing (HBP) is a well-known method of cardiac pacing which is increasingly used in everyday practice. After lead implantation in His Bundle area (HBA) capture of various tissues can be achieved: A. right ventricular myocardium near to HBP; B. cardiac conduction system selectively or nonselectively (with concomitant regional myocardium activation). The different excitability and refractory periods decide which tissue, myocardium or/and the conduction system is effectively paced. A lot of clinical trials revealed the advantage of HBP over apical ventricular pacing (AVP). HBP improves clinical (NYHA, quality of life, hospitalization rate) and echocardiographic (left ventricular dimension and ejection fraction) indicators of heart failure.
We are going to compare mechanical and electrical synchrony during the various type of myocardium activation: HBP (nsHBP or sHBP), RV pacing near HBA and native heart rhythm (if possible) in each patient recruited to the study. Adequate pacemaker programming will allow achieving different activations as shown above. The mechanical synchrony will be estimated by transthoracic echocardiography and the electrical one by the detailed analysis of ECG.
| Study Type : | Observational |
| Estimated Enrollment : | 100 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Official Title: | Mechanical and Electrical Dyssynchrony During His-Bundle Pacing (Selective and Non-selective) Versus His-Bundle Area Right Ventricular Pacing |
| Actual Study Start Date : | December 14, 2020 |
| Estimated Primary Completion Date : | June 30, 2022 |
| Estimated Study Completion Date : | December 31, 2022 |
- Other: Device Programming
Intervention includes (1) pacemaker reprogramming (2) echocardiographic parameters acquisition (3) ECG recordingOther Names:
- Echocardiography
- ECG
- Interventricular mechanical delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]InterVentricular Mechanical Dyssynchrony Parameter 1
- Interventricular mechanical delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]InterVentricular Mechanical Dyssynchrony Parameter 1
- Free-wall-LV-to-RV-delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]InterVentricular Mechanical Dyssynchrony Parameter 2
- Free-wall-LV-to-RV-delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]InterVentricular Mechanical Dyssynchrony Parameter 2
- Septal-to-posterior wall motion delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]IntraVentricular Mechanical Dyssynchrony Parameter 1
- Septal-to-posterior wall motion delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]IntraVentricular Mechanical Dyssynchrony Parameter 1
- Opposing wall motion delay [ Time Frame: Long term: 12-15 months after pacemaker implantation ]IntraVentricular Mechanical Dyssynchrony Parameter 2
- Opposing wall motion delay [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]IntraVentricular Mechanical Dyssynchrony Parameter 2
- systolic dyssynchrony index [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Ventricular Mechanical Dyssynchrony Parameter 1
- systolic dyssynchrony index [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Ventricular Mechanical Dyssynchrony Parameter 1
- QRS duration [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Electrical dyssynchrony Parameter
- QRS duration [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Electrical dyssynchrony Parameter
- Radial strain [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Additional Ventricular Mechanical Dyssynchrony Parameter 1
- Radial strain [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Additional Ventricular Mechanical Dyssynchrony Parameter 1
- Left Ventricular Ejection Fraction [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Global left ventricle function parameter
- Left Ventricular Ejection Fraction [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Global left ventricle function parameter
- Global longitudinal strain [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Global left ventricle function parameter 2
- Global longitudinal strain [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Global left ventricle function parameter 2
- Left ventricular output track velocity-time integral [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Global left ventricle function parameter 3
- Left ventricular output track velocity-time integral [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Global left ventricle function parameter 3
- Diastolic Filling Time [ Time Frame: Mid-term: 3-6 months after pacemaker implantation ]Atrioventricular Dyssynchrony Parameter
- Diastolic Filling Time [ Time Frame: Long term: 12-15 months after pacemaker implantation ]Atrioventricular Dyssynchrony Parameter
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 100 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- all adult patients after implantation of pacemaker system with pacing lead successfully captured His Bundle (selectively or/and nonselectively)
Exclusion Criteria:
- not willing or incapable to give written informed consent;
- previous implanted cardiac electronic device (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy device)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04697797
| Contact: Krzysztof A Kaczmarek, MD, PhD | +48 42 201 43 60 | krzysztof.kaczmarek@umed.lodz.pl |
| Poland | |
| Department of Electrocardiology Medical University of Lodz | Recruiting |
| Lodz, Poland, 93-216 | |
| Contact: Krzysztof A Kaczmarek, MD, PhD +48 42 201 43 60 krzysztof.kaczmarek@umed.lodz.pl | |
| Responsible Party: | Medical University of Lodz |
| ClinicalTrials.gov Identifier: | NCT04697797 |
| Other Study ID Numbers: |
RNN/147/20/KE |
| First Posted: | January 6, 2021 Key Record Dates |
| Last Update Posted: | January 27, 2022 |
| Last Verified: | January 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
His Bundle Pacing Dyssynchrony Echocardiography ECG |
|
Bradycardia Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |

